Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
TFF Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | Security
Type | | Security
Class
Title | | Fee
Calculation
or Carry
Forward
Rule | | | Amount
Registered (a) | | | Proposed
Maximum
Offering
Price Per Unit | | | Maximum
Aggregate
Offering
Price (b) | | Fee Rate | | | Amount of
Registration
Fee | |
Fees to Be
Paid | | Equity | | Common stock | | 457(o) | | | | | | | | | | | $ | 8,000,000 | | $ | 147.60 per $1,000,000 | | $ | 1,180.80 | |
| | | Equity | | Series B Warrants | | (d) | | | | | | | | | | | | | | | | | | | |
| | | Equity | | Warrants to be issued to the placement agent(c) | | (d) | | | | | | | | | | | | | | | | | | | |
| | | Equity | | Pre-Funded Warrants | | (d)(e) | | | | | | | | | | | | | | | | | | | |
| | | Equity | | Common stock underlying Series B Warrants | | 457(o) | | | | | | | | | | | $ | 8,000,000 | | $ | 147.60 per $1,000,000 | | $ | 1,180.80 | |
| | | Equity | | Common stock underlying warrants to be issued to the placement agent | | 457(o) | | | | | | | | | | | $ | 700,000 | | $ | 147.60 per $1,000,000 | | $ | 103.32 | |
| | | Equity | | Common stock underlying Pre-Funded Warrants | | (e) | | | | — | | | | — | | | | — | | | — | | | — | |
Fees
Previously
Paid | | | | — | | — | | | | — | | | | — | | | | — | | | — | | | — | |
| Total Offering Amounts | | | | | | $ | 16,700,000 | | | | | $ | 2,464.92 | |
| Total Fees Previously Paid | | | | | | | | | | | | | $ | 1,540.58 | |
| Total Fee Offsets | | | | | | | | | | | | | | — | |
| Net Fee Due | | | | | | | | | | | | | $ | 924.34 | |
| (a) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover an indeterminate number of additional shares of common stock to be offered or issued from stock splits, stock dividends or similar transactions. |
| (b) | The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act. |
| (c) | We have agreed to issue to the representative of the placement agent warrants to purchase shares of common stock representing up to 7.0% of the common stock issued in the offering (including the pre-funded warrants issued in the offering). The representative’s warrants are exercisable at a per share exercise price equal to 125% of the public offering price per share of the common stock offered hereby. |
| (d) | No separate registration fee required pursuant to Rule 457(g). |
| (e) | The registrant may issue pre-funded warrants to purchase shares of common stock in the offering. The purchase price of each pre-funded warrant will equal the price per share at which shares of common shares are being sold to the public in this offering, minus $0.0001, which constitutes the pre-funded portion of the exercise price, and the remaining unpaid exercise price of the pre-funded warrant will equal $0.0001 per share (subject to adjustment as provided for therein). The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $8,000,000. |
